A Randomized Placebo-controlled Study of Baclofen ER on Brain and Behavioral Outcomes in Cocaine Dependence

Trial Profile

A Randomized Placebo-controlled Study of Baclofen ER on Brain and Behavioral Outcomes in Cocaine Dependence

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Baclofen (Primary)
  • Indications Cocaine abuse
  • Focus Biomarker; Therapeutic Use
  • Acronyms CURE
  • Most Recent Events

    • 06 Sep 2016 Planned End Date changed from 1 Jun 2017 to 1 nov 2014.
    • 06 Sep 2016 Planned initiation date changed from 1 Jan 2014 to 1 Nov 2013.
    • 06 Sep 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top